Quinazolines, pharmaceutical compositions, and therapeutic applications
US-12419962-B2 · Sep 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Papa Patrick patents
Papa Patrick is listed as an inventor on 36 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Papa Patrick |
| Total patents | 36 |
| First publication | Feb 19, 2015 |
| Latest publication | Sep 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-12404241-B2 · Sep 2, 2025 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2025186434-A1 · Jun 12, 2025 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-2024368083-A1 · Nov 7, 2024 · US
Estrogen receptor degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024368121-A1 · Nov 7, 2024 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024197888-A1 · Jun 20, 2024 · US
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024190885-A1 · Jun 13, 2024 · US
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024190883-A1 · Jun 13, 2024 · US
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024174643-A1 · May 30, 2024 · US
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
US-2024124418-A1 · Apr 18, 2024 · US
Recent patents
Latest publications not already listed above.
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
US-2024025863-A1 · Jan 25, 2024 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-11873283-B2 · Jan 16, 2024 · US
Quinazolines, pharmaceutical compositions, and therapeutic applications
US-2023293702-A1 · Sep 21, 2023 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2023119470-A1 · Apr 20, 2023 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-2023002321-A1 · Jan 5, 2023 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-11325889-B2 · May 10, 2022 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-11292796-B2 · Apr 5, 2022 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-11149007-B2 · Oct 19, 2021 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2020262840-A1 · Aug 20, 2020 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-2020199073-A1 · Jun 25, 2020 · US
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
US-2020199074-A1 · Jun 25, 2020 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10683298-B2 · Jun 16, 2020 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2019077806-A1 · Mar 14, 2019 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10167290-B2 · Jan 1, 2019 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2017342080-A1 · Nov 30, 2017 · US
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
US-9783505-B2 · Oct 10, 2017 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-9771371-B2 · Sep 26, 2017 · US
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
US-9556126-B2 · Jan 31, 2017 · US
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
US-2016354374-A1 · Dec 8, 2016 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2016024101-A1 · Jan 28, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Signal Pharm Llc | 18 |
| Biotheryx Inc | 10 |
| Celgene Corp | 8 |
| Bio Theryx Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 29 |
| C07D471/04 | 22 |
| A61P29/00 | 19 |
| C07D401/12 | 19 |
| A61P43/00 | 18 |